Box plots showing the distribution of CR and NANA urinary metabolite levels in the (A) exploratory cohort and (B) validation cohort were quantitatively measured by UPLC–MS/MS in the study participants. Kruskal–Wallis ANOVA; posthoc multiple comparisons, ****P < 0.0001; **P < 0.01. LCC, lung cancer cases; x͂ = median.
No takes yet. Share an insight, caveat, or question.
Dalal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: